These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 9572317)

  • 1. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR
    Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of nonsteroidal anti-inflammatory drugs.
    Tenenbaum J
    Can J Gastroenterol; 1999 Mar; 13(2):119-22. PubMed ID: 10203429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.
    Hollenz M; Stolte M; Leodolter A; Labenz J
    Dig Dis; 2006; 24(1-2):189-94. PubMed ID: 16699277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia.
    Yap PR; Goh KL
    Curr Pharm Des; 2015; 21(35):5073-81. PubMed ID: 26369685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
    Goldstein JL
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ; Kimmey MB
    Dig Dis; 1995; 13(2):119-29. PubMed ID: 7586632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.
    Visser LE; Graatsma HH; Stricker BH
    Br J Clin Pharmacol; 2002 Feb; 53(2):183-8. PubMed ID: 11851642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
    El-Serag HB; Graham DY; Richardson P; Inadomi JM
    Arch Intern Med; 2002 Oct; 162(18):2105-10. PubMed ID: 12374519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse gastrointestinal effects of NSAIDs: consequences and costs.
    Bidaut-Russell M; Gabriel SE
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):739-53. PubMed ID: 11566038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
    Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons.
    Griffin MR; Ray WA; Schaffner W
    Ann Intern Med; 1988 Sep; 109(5):359-63. PubMed ID: 3261560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.